iPHONE WARNING: Obsolete? 
Why is Jeff Brown throwing away a perfectly good $1,000 iPhone?

According to him, Apple is about to make a critical announcement that will send shockwaves through Wall Street.

If you own a smartphone, click here now… Because this is guaranteed to affect you.

HINT: The iPhone days are coming to an end.
Click here now.
Daniel Jeffrey Moore, insider at LivaNova
Daniel Jeffrey Moore Insider Alerts

Get notified the next time Daniel Jeffrey Moore buys or sells LivaNova stock. Enter your email address below to get our daily insider buying and selling report.

Daniel Jeffrey Moore Insider Information

Director of LivaNova
Daniel Moore has primarily worked as a private investor over the past five years. Mr. Moore served as President and CEO and a member of the board of Cyberonics, Inc., a medical device company with core expertise in neuromodulation, from 2007 to 2015 when Cyberonics merged with Sorin S.p.A. to form the Company. Mr. Moore joined Cyberonics after 18 years with Boston Scientific where he was President of InterContinental as well as having roles in general management, sales and marketing earlier in his career. Mr. Moore has a B.A. from Harvard College and an Executive M.B.A. from Boston University.

Mr. Moore has extensive experience working with cutting edge medical device companies, including leadership of Cyberonics. He has significant experience in domestic and international general management and sales and marketing. Mr. Moore serves or has served on the boards of several medical device companies, the Epilepsy Foundation of America and other non-profits focused on epilepsy, the Medical Device Manufacturers Association and the Advisory Board of Purdue University’s Weldon School of Biomedical Engineering.

What is Daniel Jeffrey Moore's net worth?

The estimated net worth of Daniel Jeffrey Moore is at least $2.59 million as of September 1st, 2021. Mr. Moore owns 31,630 shares of LivaNova stock worth more than $2,586,385 as of January 20th. This net worth approximation does not reflect any other investments that Mr. Moore may own. Learn More.

How do I contact Daniel Jeffrey Moore?

The corporate mailing address for Mr. Moore and other LivaNova executives is 20 EASTBOURNE TERRACE, LONDON X0, W2 6LG. LivaNova can also be reached via phone at 442033250660 and via email at [email protected]

Has Daniel Jeffrey Moore been buying or selling shares of LivaNova?

Over the course of the past ninety days, Daniel Jeffrey Moore has sold $85,930.00 of LivaNova stock. Most recently, Daniel Jeffrey Moore sold 1,000 shares of the business's stock in a transaction on Monday, January 3rd. The shares were sold at an average price of $85.93, for a transaction totalling $85,930.00.

Who are LivaNova's active insiders?

LivaNova's insider roster includes Marco Dolci (SVP), and Daniel Moore (Director).

Are insiders buying or selling shares of LivaNova?

During the last year, insiders at the sold shares 9 times. They sold a total of 17,706 shares worth more than $1,473,380.86. The most recent insider tranaction occured on January, 3rd when Director Daniel Jeffrey Moore sold 1,000 shares worth more than $85,930.00. Insiders at LivaNova own 0.4 % of the company.

Information on this page was last updated on 1/3/2022.

Daniel Jeffrey Moore Insider Trading History at LivaNova

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/3/2022Sell1,000$85.93$85,930.00View SEC Filing Icon  
12/1/2021Sell1,000$81.73$81,730.00View SEC Filing Icon  
11/3/2021Sell1,000$85.25$85,250.00View SEC Filing Icon  
10/1/2021Sell1,000$80.00$80,000.00View SEC Filing Icon  
9/1/2021Sell1,000$82.40$82,400.0031,630View SEC Filing Icon  
8/2/2021Sell1,000$86.39$86,390.0032,630View SEC Filing Icon  
11/22/2019Sell3,000$80.00$240,000.0028,352View SEC Filing Icon  
9/16/2019Sell1,500$84.56$126,840.00
8/19/2019Sell1,500$80.25$120,375.00View SEC Filing Icon  
8/1/2019Sell6,000$80.00$480,000.0034,352View SEC Filing Icon  
3/15/2019Sell1,500$96.63$144,945.00View SEC Filing Icon  
2/15/2019Sell1,500$100.44$150,660.00View SEC Filing Icon  
1/15/2019Sell1,500$90.80$136,200.00View SEC Filing Icon  
12/15/2018Sell1,000$91.85$91,850.00View SEC Filing Icon  
11/15/2018Sell1,000$116.68$116,680.00View SEC Filing Icon  
10/15/2018Sell1,000$113.30$113,300.00View SEC Filing Icon  
9/17/2018Sell1,000$123.49$123,490.00View SEC Filing Icon  
8/15/2018Sell1,000$121.58$121,580.00View SEC Filing Icon  
7/16/2018Sell1,000$102.19$102,190.00View SEC Filing Icon  
5/15/2018Sell1,000$84.66$84,660.00View SEC Filing Icon  
4/16/2018Sell1,000$86.24$86,240.00View SEC Filing Icon  
3/15/2018Sell1,000$88.31$88,310.00View SEC Filing Icon  
2/15/2018Sell1,000$83.32$83,320.00View SEC Filing Icon  
1/16/2018Sell1,000$82.15$82,150.00View SEC Filing Icon  
12/15/2017Sell1,000$80.80$80,800.00View SEC Filing Icon  
11/15/2017Sell1,000$81.39$81,390.00View SEC Filing Icon  
10/16/2017Sell1,000$74.58$74,580.00View SEC Filing Icon  
9/15/2017Sell1,000$68.55$68,550.0057,296View SEC Filing Icon  
8/15/2017Sell1,000$60.76$60,760.0058,296View SEC Filing Icon  
7/17/2017Sell1,000$61.55$61,550.0056,437View SEC Filing Icon  
6/15/2017Sell1,000$60.80$60,800.0057,437View SEC Filing Icon  
4/17/2017Sell1,000$51.32$51,320.0059,437View SEC Filing Icon  
3/15/2017Sell1,000$50.21$50,210.0060,437View SEC Filing Icon  
5/24/2016Sell1,000$50.07$50,070.0064,137View SEC Filing Icon  
4/15/2016Sell1,000$54.81$54,810.0064,437View SEC Filing Icon  
3/15/2016Sell1,000$56.88$56,880.0065,437View SEC Filing Icon  
2/16/2016Sell1,000$56.88$56,880.0066,437View SEC Filing Icon  
1/15/2016Sell1,000$52.64$52,640.0067,437View SEC Filing Icon  
12/15/2015Sell2,500$53.97$134,925.0068,437View SEC Filing Icon  
See Full Table

Daniel Jeffrey Moore Buying and Selling Activity at LivaNova

This chart shows Daniel Jeffrey Moore's buying and selling at LivaNova by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

LivaNova Company Overview

LivaNova logo
LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. It operates through the Cardiovascular and Neuromodulation segments. The Cardiovascular segment develops, produces, and sells cardiopulmonary products, heart valves, and circulatory support products. The Neuromodulation segment designs, develops, and markets Neuromodulation therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression (DTD), and obstructive sleep apnea. The company was founded in 1987 and is headquartered in London, the United Kingdom.
Read More

Today's Range

Now: $81.77
Low: $81.76
High: $84.79

50 Day Range

MA: $84.05
Low: $77.30
High: $90.44

2 Week Range

Now: $81.77
Low: $61.76
High: $93.89

Volume

336,602 shs

Average Volume

271,792 shs

Market Capitalization

$4.35 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.9
iPHONE WARNING: Obsolete? 
Why is Jeff Brown throwing away a perfectly good $1,000 iPhone?

According to him, Apple is about to make a critical announcement that will send shockwaves through Wall Street.

If you own a smartphone, click here now… Because this is guaranteed to affect you.

HINT: The iPhone days are coming to an end.
Click here now.